Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up

The American Journal of Psychiatry
Peter MilevNancy C Andreasen

Abstract

The relationship between cognition and outcome in people with schizophrenia has been established in studies that, for the most part, examined chronic patients and were cross-sectional in design. The purpose of this study was to analyze the relationships between neurocognitive variables assessed at illness onset and functional outcome in a longitudinal design. An additional area of interest was whether the severity of negative symptoms would predict outcome independently from neurocognitive variables or whether there would be an overlap in their predictive power. The authors administered a comprehensive cognitive battery and clinical assessments to 99 subjects who were in their first episode of illness and analyzed the relationship of cognition and symptom severity at intake with community outcome after an average follow-up period of 7 years. Verbal memory, processing speed and attention, and the severity of negative symptoms at intake were related to subsequent outcome. Global psychosocial functioning was predicted by negative symptoms and attention. Verbal memory was the significant predictor of the degree of impairment in recreational activities. Impairment in relationships was predicted by negative symptoms and memory, where...Continue Reading

References

Mar 27, 2013·Social Psychiatry and Psychiatric Epidemiology·Christy Lai-Ming HuiEric Yu-Hai Chen
Sep 4, 2008·Psychopharmacology·Cherrie Galletly
Oct 13, 2006·European Archives of Psychiatry and Clinical Neuroscience·Margot AlbusHelmut Küchenhoff
Dec 5, 2008·European Archives of Psychiatry and Clinical Neuroscience·Wolfgang WölwerGerman Study Group on First Episode Schizophrenia
Mar 9, 2011·European Archives of Psychiatry and Clinical Neuroscience·Sofia BrissosMaria Luisa Figueira
Jul 28, 2011·European Archives of Psychiatry and Clinical Neuroscience·János M RéthelyiIstván Bitter
Aug 2, 2006·Current Psychiatry Reports·Daniel Wolf
Sep 21, 2007·Current Psychiatry Reports·Adriana FosterPeter Buckley
Sep 8, 2010·Current Psychiatry Reports·Elizabeth HansonChristian Kohler
May 7, 2013·Asian Journal of Psychiatry·Wolfgang GaebelHelen-Rose Cleveland
Nov 13, 2012·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Ofer AgidGary Remington
Aug 6, 2013·Psychiatry Research·Gagan FervahaGary Remington
Aug 10, 2013·Psychiatry Research·Maike EngelTania M Lincoln
Feb 4, 2009·Psychological Medicine·C WhiteS Lewis
Sep 16, 2009·Psychological Medicine·C González-BlanchB Crespo-Facorro
Sep 24, 2010·Psychological Medicine·J W CarterS A Mednick
Dec 15, 2006·Journal of the International Neuropsychological Society : JINS·Gildas BrébionLyn S Pilowsky
Feb 11, 2009·Journal of the International Neuropsychological Society : JINS·G H M PijnenborgW H Brouwer
Apr 9, 2010·Journal of the International Neuropsychological Society : JINS·Kandice J VarcinJulie D Henry
Apr 5, 2012·Journal of the International Neuropsychological Society : JINS·Heather A BaitzWilliam G Honer
Feb 5, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Margaret M McClureLarry J Siever
Jun 13, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Robert A LasserJean-Pierre Lindenmayer
Apr 9, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Alexandre SeillierAndrea Giuffrida
Jul 11, 2007·The Australian and New Zealand Journal of Psychiatry·Kathryn MillerDennis Velakoulis
Jul 9, 2008·Journal of Clinical and Experimental Neuropsychology·Gildas BrébionLyn S Pilowsky
Nov 5, 2011·Social Neuroscience·Junghee LeeMichael F Green
Feb 8, 2006·Schizophrenia Bulletin·Thomas H McGlashan
Nov 14, 2006·Schizophrenia Bulletin·Robert W Buchanan
Jul 23, 2008·Schizophrenia Bulletin·George Foussias, Gary Remington
Aug 1, 2008·Schizophrenia Bulletin·R Walter HeinrichsStephanie McDermid Vaz
Apr 14, 2006·Current Opinion in Psychiatry·Alex D TullochAnthony S David
Sep 3, 2013·The Journal of Nervous and Mental Disease·Casey SarapasRobert N Faull
Jun 10, 2009·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Martín L VargasJuan José Marín
May 1, 2012·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Juan Carlos SanzJuan José Marín

Related Concepts

Prevalence Studies
Individual Adjustment
Schizophrenia
Memory for Designs Test
Severity of Illness Index
Longitudinal Survey
Coping Skills
Outcomes Research
Overinclusion
Schizophrenic Psychology

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.